DexCom (DXCM) Tops Q3 EPS by 16c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $80.26 -6.39%
Revenue Growth %: +9.9%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: +9.9%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.50, $0.16 better than the analyst estimate of $0.34. Revenue for the quarter came in at $975 million versus the consensus estimate of $939.19 million.
GUIDANCE:
DexCom sees FY2023 revenue of $3.575-3.6 million, versus the consensus of $3.539 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Oceaneering (OII) Misses Q3 EPS by 9c
- Medpace beats Q3 estimates but guides below on revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
